CWRU researcher receives New Innovator Award to advance synthetic platelet technology

CWRU researcher aims to stem bleeding from traumatic injury

A Case Western Reserve University researcher will receive a $2.3 million New Innovator Award today to further develop and broaden the uses of synthetic platelets and the technology that makes them work.

Erin Lavik, associate professor of biomedical engineering, uses nanotechnology to build platelets of biodegradable polymers, which link with natural platelets to stem bleeding faster.

She and fellow researchers initially pursued the technology after seeing the damage and death tolls among soldiers who received traumatic brain injuries in Afghanistan and Iraq.

The award, presented by the National Institutes of Health, is designed specifically to support unusually creative new investigators with highly innovative research ideas at an early stage of their career.

"It will provide a wonderful foundation for supporting my students as we pursue this research," Lavik said.

Lavik's lab will continue testing and fine-tuning the artificial platelets toward use in people suffering all kinds of traumatic injuries. She also plans to develop new modes of drug delivery based on the system the synthetic platelets use to home in and lock onto clotting natural platelets.

"NIH is pleased to be supporting early-stage investigators from across the country who are taking considered risks in a wide range of areas in order to accelerate research," said Francis S. Collins, M.D., Ph.D., director of the National Institutes. "We look forward to the results of their work."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy